Prosecution Insights
Last updated: October 02, 2026

Cytek Biosciences Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

Cytek Biosciences Inc. currently manages 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 5 actions are distributed across 5 distinct examiners and 4 distinct art units, showing a high degree of dispersion. This suggests that the company's biotechnology innovations are being reviewed by several different technical groups at the patent office, each with its own specific focus and examination standards.

The busiest examiner for the portfolio is IVICH, FERNANDO NMN, who is responsible for 1 pending office action. Because each of the 5 pending actions is assigned to a different examiner, there is no concentration of workload under any single individual. This requires practitioners to adapt to five different examination styles and sets of preferences simultaneously. The lack of examiner overlap means that every pending matter represents a unique prosecution track.

The involvement of 4 distinct art units indicates that the 5 pending office actions cover a variety of technical sub-fields within biotechnology. With 5 distinct examiners involved, the company must manage five separate prosecution timelines. Success in this environment depends on a coordinated effort to address the unique requirements of each examiner across the 4 different art units currently engaged with the portfolio. Practitioners should ensure that the strategy for each of the 5 pending actions is tailored to the specific examiner assigned.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other2 (40%)
Multi-statute (no §101)3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
40% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
IVICH, FERNANDO NMN 1 48.7% +69.8%
TRAN, CHAU NGUYEN BICH 1 31.6% +45.2%
KWAK, DEAN P 1 58.7% +37.1%
COOK, JONATHON 1 81.6% +17.0%
BRYANT, REBECCA CAROLE 1 64.8% +32.5%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17994395 METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS COOK, JONATHON 77d overdue
18297615 METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS KWAK, DEAN P 44d overdue
16418942 FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS BRYANT, REBECCA CAROLE 14d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17994395 METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS COOK, JONATHON 77d overdue
18297615 METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS KWAK, DEAN P 44d overdue
16418942 FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS BRYANT, REBECCA CAROLE 14d
18747407 ULTRA-BRIGHT NANOPARTICLE FLUORESCENT DYE COMPLEXES IVICH, FERNANDO NMN —
18353056 B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS TRAN, CHAU NGUYEN BICH —

Top Art Units

Art UnitApps
2877 2
1657 1
1677 1
1798 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18747407 ULTRA-BRIGHT NANOPARTICLE FLUORESCENT DYE COMPLEXES IVICH, FERNANDO NMN 1657 §102§112DP Non-Final OA — Pending Jun 18, 2024
18353056 B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS TRAN, CHAU NGUYEN BICH 1677 §103§112DP Non-Final OA — Pending Jul 14, 2023
18297615 METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS KWAK, DEAN P 1798 §102§103§112 Final Rejection 44d overdue Pending Apr 08, 2023
17994395 METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS COOK, JONATHON 2877 §102§103 Non-Final OA 77d overdue Pending Nov 28, 2022
16418942 FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS BRYANT, REBECCA CAROLE 2877 §102§103§112 Non-Final OA 14d Pending May 21, 2019

Managing Cytek Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month